CardioVue is building next-generation ECG intelligence for scalable, real-time cardiac diagnostics.
Our unique AI model interprets full-length, multi-lead ECG signals with clinical-grade accuracy across multiple conditions. Designed to detect multiple cardiovascular issues, CardioVue delivers fast, reliable, and seamlessly integrable ECG classification. By analyzing full signal data along with key patient factors - such as age, sex, and comorbidities - we support clinical decision-making, without sacrificing interpretability or precision.
Out current model performance signifies:
1) F1 scores >0.90 across key arrhythmias and conduction disorders
2) High specificity and precision across 5+ cardiac pathologies
3) Low-latency inference and small footprint - optimized for edge deployment
Whether you’re building consumer wearables, remote monitoring solutions, or building clinical-grade ECG tools and want to expand your capabilities, we'd love to talk.
We’re currently working with multiple labs, but we're also exploring:
📄 Licensing opportunities
🧪 Joint validation with device makers
🤝 Strategic partnerships for deployment
If you'd like to learn more or explore collaboration, feel free to reach out - we’re always open to new conversations!
Company Details
- Employees
- 2
- Founded
- -
- Address
- Toronto, Ontario, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.cardiovue.ca/
- Keywords
- AI, Health, Cardiovascular Issues, Hardware.
- HQ
- Toronto, Ontario
Cardiovue Questions
Cardiovue's website is https://www.cardiovue.ca/
Cardiovue's LinkedIn profile is https://ca.linkedin.com/company/cardiovue
Cardiovue has
2 employees.
View email and phone details for 2
employees at Cardiovue.
Cardiovue's industry is
Biotechnology Research
Cardiovue's top competitors are
Kuiperworks,
Clearcardio Llc,
Upfirst,
Queen's Cardiac Research Committee,
Innovation Boost Zone,
Servicio Madrileño De Salud,
Dmz,
Pellonia,
Avid Technology Development,
Uppfirst.
Cardiovue's categories are Biotechnology Research
Cardiovue's founding year is 2022
